Integrin interaction inhibitors for the treatment of cancer
US-10059740-B2 · Aug 28, 2018 · US
US10556928B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10556928-B2 |
| Application number | US-201816157174-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 11, 2018 |
| Priority date | Mar 31, 2014 |
| Publication date | Feb 11, 2020 |
| Grant date | Feb 11, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The current invention pertains to stabilized peptoids or peptoid-peptide hybrids. The peptoids or peptoid-peptide hybrids are stabilized by side chain-side to side chain linkages and/or backbone cyclization. The current invention also provides a positional library scanning method for identification of peptoids or peptoid-peptide hybrids having a desired biological activity.
Opening claim text (preview).
We claim: 1. A method of positional library scanning for identification of a peptoid or a peptoid-peptide hybrid having a desired biological activity, the method comprising: a. producing a library of the peptoids having a core peptoid structure or the peptoid-peptide hybrids having a core peptoid-peptide structure, wherein the library consists of compounds having various combinations of possible side chains on a number of possible substitution positions on the core peptoid or the core peptoid-peptide hybrid, wherein each peptoid comprises a plurality of N-substituted glycines, wherein at least two of the N-substituted glycines are linked to each other by an intramolecular cross-link between the N-substitutions, and wherein the length and geometry of the cross-link pre-organizes the peptoid into a desired conformation, and wherein each peptoid-peptide hybrid comprises a plurality of amino acids and a plurality of N-substituted glycines, wherein at least two residues from the plurality of amino acids and the plurality of N-substituted glycines are linked to each other by an intramolecular cross-link, and wherein the length and geometry of the intramolecular cross-link provides stability to the peptoid-peptide hybrid, b. producing a positional scanning library comprising an array of spots containing the peptoids or the peptoid-peptide hybrids, c. conducting an assay for the desired biological activity to identify one or more spots on the positional scanning library that display the desired biological activity, and d. further testing the compounds present in the spots that display the desired biological activity to identify the compounds having the desired biological activity. 2. The method of claim 1 , wherein the desired biological activity is a specific interaction with a biomolecule. 3. The method of claim 2 , wherein the biomolecule is selected from a polypeptide or a nucleic acid molecule. 4. The method of claim 1 , wherein the library of peptoids comprises one or more stabled peptoids comprising a plurality of N-substituted glycines, wherein at least two of the N-substituted glycines are linked to each other by an intramolecular cross-link between the N-substitutions, and wherein the length and geometry of the cross-link pre-organizes the peptoid into a desired conformation. 5. The method of claim 1 , wherein the library of peptoids comprises one or more stapled peptoid-peptide hybrids comprising a plurality of amino acids and a plurality of N-substituted glycines, wherein at least two residues from the plurality of amino acids and the plurality of N-substituted glycines are linked to each other by an intramolecular cross-link, and wherein the length and geometry of the intramolecular cross-link provides stability to the peptoid-peptide hybrid. 6. A method for the analysis of a library of peptoid-peptide hybrids to identify a peptoid-peptide hybrid capable of binding to one or more biomolecules, comprising the steps of: a) providing an array comprising a combinatorial peptoid-peptide library, b) providing a first cell expressing one or more biomolecules of interest, wherein the first cell is labeled with a first label, c) providing a second cell not expressing the one or more biomolecules of interest, wherein the second cell is labeled with a second label distinguishable from the first label, d) contacting the first cell and the second cell to the combinatorial peptoid-peptide library, e) identifying, from the combinatorial peptoid-peptide library, the peptoid-peptide hybrid capable of binding to one or more biomolecules as indicated by the presence of the first label and the absence of the second label on the one or more positions on the array corresponding to the peptoid-peptide hybrid molecules wherein each peptoid-peptide hybrid comprises a plurality of amino acids and a plurality of N-substituted glycines, wherein at least two residues from the plurality of amino acids and the plurality of N-substituted glycines are linked to each other by an intramolecular cross-link, and wherein the length and geometry of the intramolecular cross-link provides stability to the peptoid-peptide hybrid. 7. The method of claim 6 , wherein the one or more biomolecules comprise a protein, nucleotide, lipid, polysaccharide, or a combination thereof. 8. The method of claim 7 , wherein the protein is a cytoplasmic protein or a cell surface protein. 9. The method of claim 8 , wherein the cell surface protein comprises 41BB receptor and TNF-β receptor. 10. The method of claim 6 , wherein the first label and the second label are a fluorescent label, a quantum dot label, a radiolabel, an enzyme label, a chromophore label, a chemiluminescent label, or an antibody label. 11. The method of claim 6 , wherein the first label is a quantum dot of a first color and the second label is a quantum dot of a second color. 12. The method of claim 6 , wherein the array comprising the peptoid-peptide library comprises spots of peptide-peptoid hybrids in the library on a solid support in a multi-well containing peptide-peptoid hybrids in the library.
involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)} · CPC title
Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins · CPC title
Methods of identifying protein-protein interactions in protein mixtures · CPC title
Cyclic peptides containing only normal peptide links · CPC title
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.